Coverage
-
May 06, 2019
Amarin Pharma Inc. on Monday announced legal settlements with two dietary supplement sellers that allegedly hijacked results from the drugmaker's high-profile study of omega-3 fatty acids, adding that it has attorneys "on speed dial" to sue other supplement makers if needed.
1 other articles on this case.
View all »